OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 5.95
+0.07 (1.19%)
Sep 29, 2025, 5:35 PM CET
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €135.05 million as of September 29, 2025. Its market cap has decreased by -17.22% in one year.
Market Cap
135.05M
Enterprise Value
122.07M
Revenue
83.44M
Ranking
n/a
PE Ratio
4.03
Stock Price
€5.95
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 104.30M to 135.05M, an increase of 29.48%. That is a compound annual growth rate of 2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 135.05M | -13.89% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | 129.02M | 133.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.29B |
| Sanofi | 95.30B |
| Sartorius Stedim Biotech | 16.69B |
| bioMérieux | 13.34B |
| Eurofins Scientific SE | 10.82B |
| Ipsen | 9.19B |
| ABIVAX Société Anonyme | 5.31B |
| Virbac | 2.63B |